BO
Bank of America Corp cut its INBX stake below 5%
Bank of America Corp reported owning 2.4% of Inhibrx Biosciences, Inc. (INBX) (357,318 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 28, 2026
- Source
- Schedule 13G